US Stock MarketDetailed Quotes

AKBA Akebia Therapeutics

Watchlist

1.4700
+0.0300+2.08%

Trading Sep 13 10:13 ET

309.12MMarket Cap-7000P/E (TTM)

Akebia Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-377.38%-10.07M

-10.80%-19.43M

68.03%-23.38M

95.78%-2.31M

-121.20%-7.17M

111.84%3.63M

18.88%-17.54M

71.08%-73.15M

12.94%-54.68M

160.08%33.81M

Net income from continuing operations

23.20%-8.58M

33.08%-17.99M

44.89%-51.93M

110.11%614K

73.22%-14.49M

-139.40%-11.17M

56.94%-26.88M

66.59%-94.23M

91.31%-6.07M

9.15%-54.1M

Operating gains losses

---2.33M

--423K

-16.21%-760K

----

-9.00%-654K

--0

--56K

Depreciation and amortization

0.03%9.41M

-0.36%9.38M

-0.19%37.63M

-0.16%9.4M

-0.18%9.41M

-0.20%9.41M

-0.72%37.7M

-0.36%9.42M

-0.63%9.42M

Other non cash items

305.84%2.54M

238.79%952K

102.40%1.5M

103.78%2.87M

-102.86%-418K

45.15%-1.23M

-69.85%281K

-264.98%-62.62M

-552.15%-75.91M

460.11%14.61M

Change In working capital

-576.86%-13.64M

-376.92%-15.15M

-1,336.38%-20.73M

-200.28%-16.21M

-107.27%-4.21M

103.80%2.86M

-114.93%-3.18M

98.63%-1.44M

82.94%-5.4M

712.71%57.89M

-Change in receivables

-273.96%-3.15M

-41.21%12.67M

-91.20%994K

1.86%-16.7M

-105.14%-3.02M

94.97%-841K

257.24%21.55M

147.02%11.3M

-1,329.83%-17.02M

499.95%58.73M

-Change in inventory

-528.78%-14.93M

-160.35%-4.43M

-113.32%-2.54M

-148.18%-11.78M

-58.52%-1.59M

293.33%3.48M

240.02%7.35M

176.51%19.09M

136.59%24.45M

-334.35%-1M

-Change in prepaid assets

-142.48%-130K

-80.86%1.41M

1,019.00%11.84M

120.55%1.8M

-74.46%2.36M

103.62%306K

-18.19%7.38M

105.67%1.06M

-237.38%-8.74M

132.62%9.24M

-Change in payables and accrued expense

171.35%7.29M

33.94%-22.55M

58.18%-15.27M

235.39%8.22M

174.49%7.96M

110.61%2.69M

-1,063.98%-34.13M

-7.95%-36.5M

107.21%2.45M

-162.87%-10.68M

-Change in other current assets

134.76%1.07M

78.20%-613K

75.80%-1.36M

125.56%6.81M

-120.86%-2.3M

-145.63%-3.06M

-185.29%-2.81M

31.54%-5.62M

-105.95%-26.65M

1,803.11%11.02M

-Change in other current liabilities

-1,167.35%-3.11M

-290.44%-2.33M

-332.21%-10.65M

-125.83%-4.56M

-35.19%-7.61M

106.01%291K

147.53%1.22M

105.83%4.59M

1,570.17%17.64M

-1,626.29%-5.63M

-Change in other working capital

----

118.59%695K

-180.32%-3.74M

--0

-111.19%-3.74M

155.57%4.65M

293.66%2.47M

-124.90%-3.78M

Cash from discontinued investing activities

Operating cash flow

-377.38%-10.07M

-10.80%-19.43M

68.03%-23.38M

95.78%-2.31M

-121.20%-7.17M

111.84%3.63M

18.88%-17.54M

71.08%-73.15M

12.94%-54.68M

160.08%33.81M

Investing cash flow

Cash flow from continuing investing activities

-100.29%-114K

Net PPE purchase and sale

----

--0

----

-93.22%-114K

--0

Cash from discontinued investing activities

Investing cash flow

---29K

--0

-100.29%-114K

--0

Financing cash flow

Cash flow from continuing financing activities

195.50%7.64M

215.71%18.48M

-272.67%-25.21M

-128,900.00%-1.29M

100.15%50K

-88,788.89%-8M

-133.58%-15.97M

-89.08%14.6M

-100.02%-1K

-299.84%-32.94M

Net issuance payments of debt

195.33%7.63M

101.71%274K

3.03%-32M

---8M

--0

---8M

---16M

---33M

--0

---33M

Net common stock issuance

--750K

53,017.65%18.06M

-9.80%6.79M

671,000.00%6.71M

-20.63%50K

--0

-99.55%34K

-91.53%7.53M

-100.02%-1K

-99.62%63K

Proceeds from stock option exercised by employees

--14K

--141K

-98.51%1K

--1K

--0

--67K

--0

Net other financing activities

----

-10.68%40M

--0

Cash from discontinued financing activities

Financing cash flow

195.50%7.64M

215.71%18.48M

-272.67%-25.21M

-128,900.00%-1.29M

100.15%50K

-88,788.89%-8M

-133.58%-15.97M

-89.08%14.6M

-100.02%-1K

-299.84%-32.94M

Net cash flow

Beginning cash position

-26.89%43.62M

-52.15%44.58M

-38.64%93.17M

-67.41%48.18M

-62.38%55.29M

-66.41%59.67M

-38.64%93.17M

-34.31%151.84M

-29.34%147.85M

-40.98%146.98M

Current changes in cash

43.83%-2.46M

97.14%-957K

17.18%-48.59M

93.42%-3.6M

-919.93%-7.12M

85.75%-4.37M

-229.81%-33.5M

26.01%-58.67M

4.75%-54.68M

102.18%868K

End cash Position

-25.55%41.17M

-26.89%43.62M

-52.15%44.58M

-67.41%48.18M

-62.38%55.29M

-66.41%59.67M

-38.64%93.17M

-29.34%147.85M

Free cash flow

-378.18%-10.1M

-10.80%-19.43M

68.08%-23.38M

95.78%-2.31M

-121.20%-7.17M

111.84%3.63M

19.31%-17.54M

71.04%-73.27M

12.94%-54.68M

160.08%33.81M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-377.38%-10.07M	-10.80%-19.43M	68.03%-23.38M	95.78%-2.31M	-121.20%-7.17M	111.84%3.63M	18.88%-17.54M	71.08%-73.15M	12.94%-54.68M	160.08%33.81M
Net income from continuing operations	23.20%-8.58M	33.08%-17.99M	44.89%-51.93M	110.11%614K	73.22%-14.49M	-139.40%-11.17M	56.94%-26.88M	66.59%-94.23M	91.31%-6.07M	9.15%-54.1M
Operating gains losses	---2.33M	--423K	-16.21%-760K	----	----	----	----	-9.00%-654K	--0	--56K
Depreciation and amortization	0.03%9.41M	-0.36%9.38M	-0.19%37.63M	-0.16%9.4M	-0.18%9.41M	-0.20%9.41M	-0.20%9.41M	-0.72%37.7M	-0.36%9.42M	-0.63%9.42M
Other non cash items	305.84%2.54M	238.79%952K	102.40%1.5M	103.78%2.87M	-102.86%-418K	45.15%-1.23M	-69.85%281K	-264.98%-62.62M	-552.15%-75.91M	460.11%14.61M
Change In working capital	-576.86%-13.64M	-376.92%-15.15M	-1,336.38%-20.73M	-200.28%-16.21M	-107.27%-4.21M	103.80%2.86M	-114.93%-3.18M	98.63%-1.44M	82.94%-5.4M	712.71%57.89M
-Change in receivables	-273.96%-3.15M	-41.21%12.67M	-91.20%994K	1.86%-16.7M	-105.14%-3.02M	94.97%-841K	257.24%21.55M	147.02%11.3M	-1,329.83%-17.02M	499.95%58.73M
-Change in inventory	-528.78%-14.93M	-160.35%-4.43M	-113.32%-2.54M	-148.18%-11.78M	-58.52%-1.59M	293.33%3.48M	240.02%7.35M	176.51%19.09M	136.59%24.45M	-334.35%-1M
-Change in prepaid assets	-142.48%-130K	-80.86%1.41M	1,019.00%11.84M	120.55%1.8M	-74.46%2.36M	103.62%306K	-18.19%7.38M	105.67%1.06M	-237.38%-8.74M	132.62%9.24M
-Change in payables and accrued expense	171.35%7.29M	33.94%-22.55M	58.18%-15.27M	235.39%8.22M	174.49%7.96M	110.61%2.69M	-1,063.98%-34.13M	-7.95%-36.5M	107.21%2.45M	-162.87%-10.68M
-Change in other current assets	134.76%1.07M	78.20%-613K	75.80%-1.36M	125.56%6.81M	-120.86%-2.3M	-145.63%-3.06M	-185.29%-2.81M	31.54%-5.62M	-105.95%-26.65M	1,803.11%11.02M
-Change in other current liabilities	-1,167.35%-3.11M	-290.44%-2.33M	-332.21%-10.65M	-125.83%-4.56M	-35.19%-7.61M	106.01%291K	147.53%1.22M	105.83%4.59M	1,570.17%17.64M	-1,626.29%-5.63M
-Change in other working capital	----	118.59%695K	-180.32%-3.74M	--0	--0	--0	-111.19%-3.74M	155.57%4.65M	293.66%2.47M	-124.90%-3.78M
Cash from discontinued investing activities
Operating cash flow	-377.38%-10.07M	-10.80%-19.43M	68.03%-23.38M	95.78%-2.31M	-121.20%-7.17M	111.84%3.63M	18.88%-17.54M	71.08%-73.15M	12.94%-54.68M	160.08%33.81M
Investing cash flow
Cash flow from continuing investing activities			0	0	0			-100.29%-114K	0	0
Net PPE purchase and sale	----	----	--0	--0	--0	----	----	-93.22%-114K	--0	--0
Cash from discontinued investing activities
Investing cash flow	---29K	--0	--0	--0	--0	--0	--0	-100.29%-114K	--0	--0
Financing cash flow
Cash flow from continuing financing activities	195.50%7.64M	215.71%18.48M	-272.67%-25.21M	-128,900.00%-1.29M	100.15%50K	-88,788.89%-8M	-133.58%-15.97M	-89.08%14.6M	-100.02%-1K	-299.84%-32.94M
Net issuance payments of debt	195.33%7.63M	101.71%274K	3.03%-32M	---8M	--0	---8M	---16M	---33M	--0	---33M
Net common stock issuance	--750K	53,017.65%18.06M	-9.80%6.79M	671,000.00%6.71M	-20.63%50K	--0	-99.55%34K	-91.53%7.53M	-100.02%-1K	-99.62%63K
Proceeds from stock option exercised by employees	--14K	--141K	-98.51%1K	--1K	--0	--0	--0	--67K	--0	--0
Net other financing activities	----	----	----	----	----	----	----	-10.68%40M	--0	--0
Cash from discontinued financing activities
Financing cash flow	195.50%7.64M	215.71%18.48M	-272.67%-25.21M	-128,900.00%-1.29M	100.15%50K	-88,788.89%-8M	-133.58%-15.97M	-89.08%14.6M	-100.02%-1K	-299.84%-32.94M
Net cash flow
Beginning cash position	-26.89%43.62M	-52.15%44.58M	-38.64%93.17M	-67.41%48.18M	-62.38%55.29M	-66.41%59.67M	-38.64%93.17M	-34.31%151.84M	-29.34%147.85M	-40.98%146.98M
Current changes in cash	43.83%-2.46M	97.14%-957K	17.18%-48.59M	93.42%-3.6M	-919.93%-7.12M	85.75%-4.37M	-229.81%-33.5M	26.01%-58.67M	4.75%-54.68M	102.18%868K
End cash Position	-25.55%41.17M	-26.89%43.62M	-52.15%44.58M	-52.15%44.58M	-67.41%48.18M	-62.38%55.29M	-66.41%59.67M	-38.64%93.17M	-38.64%93.17M	-29.34%147.85M
Free cash flow	-378.18%-10.1M	-10.80%-19.43M	68.08%-23.38M	95.78%-2.31M	-121.20%-7.17M	111.84%3.63M	19.31%-17.54M	71.04%-73.27M	12.94%-54.68M	160.08%33.81M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data